Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -4 of 4 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Phase 2a Study of AdV-tk With Standard Radiation Therapy for Malignant Glioma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Pharmaceutical / Industry				BrTK02 5R44CA107745, NCT00589875

Last Modified: 10/15/2008 First Published: 8/5/2008


2.		Phase I Study of Adjuvant Adenoviral Vector Encoding Herpes Simplex Virus Thymidine Kinase Followed by Valacyclovir and Radiotherapy in Pediatric Patients With Newly Diagnosed, Supratentorial Malignant Glioma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Active				3 to 17				Other, Pharmaceutical / Industry				DFCI-07098 07-098, ADVANTAGENE-DFCI-07098, NCT00729105


3.		AdV-tk Therapy With Surgery and Chemoradiation for Pancreas Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Active				18 and over				Pharmaceutical / Industry				PaTK01 1R43CA119847, NCT00638612


4.		Phase 1b Study of AdV-tk + Valacyclovir Combined With Radiation Therapy for Malignant Gliomas

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Active				18 and over				Pharmaceutical / Industry				BrTK01 5R44CA107745, NCT00751270

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute